MedTech Acquisition Corporation
MTAC · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $354 | $313 | $309 | $0 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $2 | $1 | $0 |
| Enterprise Value | $354 | $316 | $309 | -$1 |
| Revenue | $29 | $0 | $0 | – |
| % Growth | – | – | – | – |
| Gross Profit | $25 | $0 | $0 | – |
| % Margin | 86.1% | – | – | – |
| EBITDA | -$36 | -$9 | -$11 | – |
| % Margin | -122.9% | – | – | – |
| Net Income | -$33 | $6 | $5 | – |
| % Margin | -112.9% | – | – | – |
| EPS Diluted | -1.06 | 0.18 | 0.15 | – |
| % Growth | -688.9% | 20% | – | – |
| Operating Cash Flow | -$41 | -$3 | -$2 | – |
| Capital Expenditures | $0 | $0 | $0 | – |
| Free Cash Flow | -$41 | -$3 | -$2 | – |